date,title,source
Oct-23-18,Cramer's lightning round: If you want to invest in non-op...,CNBC Videos
Oct-31-18,Heron Announces FDA Submission of HTX-011 NDA for Postoperative Pain Management,PR Newswire
Nov-07-18,"Heron Therapeutics (HRTX) Reports Q3 Loss, Tops Revenue Estimates",Zacks
Nov-07-18,Heron Therapeutics: 3Q Earnings Snapshot,Associated Press
Nov-07-18,"Heron Therapeutics Announces Financial Results for the Three and Nine Months Ended September 30, 2018 and Recent Corporate Progress",PR Newswire
Nov-12-18,U.S. Surgeon General Jerome Adams Discusses Opioid Alternatives and the Importance of Partnerships at Heron Therapeutics,PR Newswire
Nov-12-18,Today's Research Reports on Trending Tickers: Heron Therapeutics and Bristol-Myers Squibb,ACCESSWIRE
Nov-20-18,Heron Therapeutics to Present at the Evercore ISI HealthCONx Conference,PR Newswire
Nov-21-18,When Will Heron Therapeutics Inc (NASDAQ:HRTX) Become Profitable?,Simply Wall St.
Nov-26-18,Today's Research Reports on Trending Tickers: Cronos Group and Heron Therapeutics,ACCESSWIRE
Nov-27-18,"Report: Exploring Fundamental Drivers Behind Aclaris Therapeutics, Extreme Networks, Care, Air Lease, Globus Medical, and Heron Therapeutics  New Horizons, Emerging Trends, and Upcoming Developments",GlobeNewswire
Nov-29-18,Today's Research Reports on Trending Tickers: Heron Therapeutics and Supernus Pharmaceuticals,ACCESSWIRE
Dec-31-18,Heron Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference,PR Newswire
Dec-31-18,Heron stock up 4.3% after opioid alternative granted priority review designation from FDA,MarketWatch
Dec-31-18,"FDA Grants Priority Review Designation for Heron Therapeutics' NDA for HTX-011, a Non-Opioid for Postoperative Pain Management",PR Newswire
